Panic Attack Treatment in Maplewood, NJ

A panic attack is an abrupt surge of intense fear or discomfort that peaks within about 10 minutes and lasts 5–20 minutes on average (sometimes extending to an hour). Physiologically, it is the sympathetic nervous system firing the full fight-or-flight response — racing heart, chest tightness, shortness of breath, sweating, trembling, dizziness, nausea, tingling in hands and feet, hot or cold flushes, and often derealization (things feel unreal) or depersonalization (you feel detached from your body). Cognitively, it is commonly accompanied by a fear of dying, losing control, or going crazy. The experience is terrifying and entirely real. It is also, medically, not dangerous on its own.

If you have ever been to an emergency room during a panic attack, you are not alone — studies show 17–25% of ED chest-pain visits actually meet criteria for panic disorder, not cardiac pathology. That statistic is not a dismissal; it is the clinical reality that the experience of a panic attack is indistinguishable from a cardiac event without objective testing. If you have not yet ruled out cardiac or thyroid pathology, that workup comes first. Once medical causes are excluded, the diagnosis of panic attacks is clinical and the treatment is highly effective.

This page covers what distinguishes a panic attack from a panic disorder, how we diagnose and treat panic disorder at our Maplewood office and over NJ-wide telehealth, what medications work, what therapy adds, and — because the searches that bring people to this page are often happening in the middle of or just after an attack — three grounding and breathing techniques you can use right now before anything else.

Panic, generalized anxiety, and a cardiac event can all produce chest tightness, shortness of breath, and racing heart — which is what makes the first panic attack so terrifying and why so many people end up in the ER. The distinctions are useful to know, though they don't substitute for a clinical workup if you're uncertain.

A panic attack has an abrupt onset, peaks within 10 minutes, and resolves within 5–60 minutes — the time-course is its most recognizable feature. Chest discomfort is typically described as pressure or tightness rather than crushing pain, and it usually doesn't radiate to the jaw or left arm. The full symptom cluster — sweating, trembling, derealization, fear of dying — is broader than typical cardiac presentations.

Generalized anxiety has a slower build, isn't peaked in the same way, and is usually tied to identifiable worry content. It rarely produces the full panic symptom cluster and doesn't usually include fear of imminent death. For patients whose panic attacks emerge alongside a pervasive mood component, we screen for depression and coordinate treatment.

A heart attack can present very similarly in the moment — especially in women, where atypical presentations are common. If you are experiencing chest pain for the first time, or if your symptoms are different from previous panic attacks, call 911 or go to the nearest emergency room. “It's probably panic” is never a diagnosis to make on yourself when the stakes are cardiac. Once you have a clear cardiac and medical workup behind you, the diagnosis of panic disorder becomes straightforward on subsequent events.

Selective serotonin reuptake inhibitors are first-line pharmacotherapy for panic disorder and have the strongest evidence base. The specific agents with FDA indications or strong published data are sertraline (Zoloft), paroxetine (Paxil), fluoxetine (Prozac), citalopram (Celexa), escitalopram (Lexapro), and fluvoxamine (Luvox). SNRIs — venlafaxine XR (Effexor) and duloxetine (Cymbalta) — are second-line with equivalent effect and are often preferred when SSRIs haven't worked or when comorbid chronic pain is part of the picture.

Panic disorder is one of the conditions where SSRIs must be started at very low doses — typically one-quarter to one-half of the standard depression starting dose — because the initial jitteriness that some SSRIs cause can feel like a panic attack and scare patients off treatment in the first week. Starting sertraline at 12.5 mg daily for 7 days before stepping to 25 mg, then 50 mg, substantially reduces that early adverse effect. We titrate up over 2–4 weeks to a therapeutic dose, often ending at the higher end of the dose range — panic disorder often requires higher doses than depression for full response.

Noticeable attack reduction typically begins around week 3–4. Full therapeutic effect arrives at 8–12 weeks. For patients who don't respond to a first SSRI at an adequate dose and duration, we switch to a different SSRI or to an SNRI; tricyclics (clomipramine, imipramine) remain effective second-line options with longer safety records. Benzodiazepines, covered below, have a specific short-term role.

Cognitive Behavioral Therapy for panic disorder is among the most effective non-pharmacologic treatments in all of psychiatry. Standard protocols run 10–14 weekly sessions and have response rates comparable to pharmacotherapy, with more durable benefits after discontinuation. The three active ingredients are psychoeducation (explaining the panic cycle so it stops feeling random and catastrophic), cognitive restructuring (identifying and challenging the catastrophic misinterpretation of physical sensations), and interoceptive exposure.

Interoceptive exposure is the piece that is specific to panic and is often the most therapeutically powerful. Panic disorder is maintained partly by fear of the physical sensations themselves — the racing heart becomes frightening, which produces more racing heart. Interoceptive exposure involves deliberately producing those sensations in a safe setting (hyperventilation to produce dizziness, breathing through a straw to produce chest tightness, running in place to produce a racing heart, spinning to produce lightheadedness) until the conditioned fear response attenuates. NIMH names interoceptive exposure explicitly as evidence-based for panic disorder — it is the signature technique and most competitors' pages gloss over it with generic “CBT.”

Teresa provides brief supportive work, panic-cycle psychoeducation, and motivational support during medication visits. For full-course CBT with interoceptive exposure, we refer to NJ-based therapists with panic-disorder CBT expertise. Most patients do medication with Teresa plus weekly CBT with a dedicated therapist for the first 3–4 months; after panic is in remission, therapy can often taper while SSRI treatment continues through the maintenance phase.

About one-third of patients with panic disorder develop agoraphobia — the avoidance of situations where escape might be difficult or help unavailable if a panic attack occurs. The classic agoraphobic pattern is progressive: first avoiding one specific place where an attack happened (a grocery store, a highway), then similar places, then eventually the home itself becomes the only safe territory. Untreated, agoraphobia can shrink the life around it in ways that are hard to reverse.

Treatment is the same as for panic disorder — SSRI plus CBT with exposure — but the therapeutic plan must explicitly include graded in-vivo exposure to the avoided situations. Exposure is done hierarchically: a feared-situation list is built from least to most, and the patient works through it week by week, often starting with brief visits to early-hierarchy situations and extending time as tolerance builds.

Telehealth is often essential in the early phase for agoraphobic patients. Coming to a clinic office is a major hurdle when home is the only safe territory; the ability to start SSRI treatment, begin psychoeducation, and coordinate therapy from home removes the first structural barrier. We often see patients via telehealth for the first 2–3 months and transition to in-person visits later, as the exposure work begins to generalize. This is a pattern where the PMHNP telehealth model is not a compromise — it is often the only path to treatment.

Panic disorder is one of the conditions where the telehealth model often fits patients better than in-person care — not because telehealth is lower-quality, but because the situations that trigger panic (waiting rooms, highway driving, crowded parking garages) are often exactly what patients need to avoid in the early weeks of treatment. Starting SSRI treatment, completing psychoeducation, and building a plan from home removes barriers that in-person-only care would impose. Once panic is in remission, some patients prefer to move to in-person visits; others continue with telehealth indefinitely. Both work clinically.

Teresa provides medication management plus brief supportive work in the same visit. Full-course weekly CBT with interoceptive exposure is referred to a dedicated therapist in New Jersey — we have several trusted referrals with panic-disorder expertise and current openings. The split-treatment model (prescriber + therapist) is the evidence-based standard and works well when both clinicians share notes with your written consent.

Emergency-room visits during a panic attack are common and not a failure of treatment. If an ER visit results in a diagnosis of panic disorder (or provisional diagnosis), bringing those records to the evaluation accelerates the process meaningfully. If you're in crisis now — not panic but acute suicidal thinking or imminent danger to yourself or others — call or text 988 (Suicide & Crisis Lifeline) any time, or call 911. Our clinic is not a 24/7 emergency service; we follow up at the next scheduled visit.